Drug Profile
Type 1 diabetes vaccine - OneVax
Latest Information Update: 06 Sep 2023
Price :
$50
*
At a glance
- Originator University of Florida
- Developer Onevax; University of Florida
- Class Antihyperglycaemics; Diabetes mellitus vaccines; Vaccines
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Type 1 diabetes mellitus
Most Recent Events
- 06 Sep 2023 Discontinued - Preclinical for Type 1 diabetes mellitus in USA (Parenteral)
- 28 Jul 2018 No recent reports of development identified for preclinical development in Type-1 diabetes mellitus in USA (Parenteral, Injection)
- 07 Jul 2016 Preclinical development is ongoing in USA